Axol Bioscience Ltd. Email Format

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Axol Bioscience Ltd. specializes in human induced pluripotent stem cell (iPSC) technologies, producing iPSC-derived cells and offering related laboratory services to support drug discovery and disease research. The company provides scalable capabilities such as iPSC banking, reprogramming, gene editing, cell manufacturing, and quality control, aiming to deliver physiologically relevant human models with improved consistency for testing compounds. Its customer base includes global pharmaceutical companies, contract research organizations, biotechnology firms, startups, and academic institutions, reflecting a broad research ecosystem. Axol's operations span neuroscience, pain and sensation, ophthalmology, dermatology, and cardiovascular research, with its base in Babraham, England.

In June 2026, Axol announced a strategic collaboration with CellVoyant Technologies to develop predictive AI assays for monitoring and optimizing cardiomyocyte manufacturing. The collaboration highlights Axol's ongoing work to enhance in vitro models and the translational potential of iPSC-based systems.

Get verified Axol Bioscience Ltd. emails free

Company overview Employee directory